New MRNA Vaccine is More Effective and Less Costly to Develop, Pitt Study Finds
June 04, 2025
June 04, 2025
PITTSBURGH, Pennsylvania, June 4 -- The University of Pittsburgh Medical Center issued the following news release:
* * *
New mRNA Vaccine is More Effective and Less Costly to Develop, Pitt Study Finds
PITTSBURGH - A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a study by researchers at University of Pittsburgh School of Public Health and the Pennsylvania State University. . . .
* * *
New mRNA Vaccine is More Effective and Less Costly to Develop, Pitt Study Finds
PITTSBURGH - A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a study by researchers at University of Pittsburgh School of Public Health and the Pennsylvania State University. . . .